BMP-2 Quantikine PharmPak (50 Plates)

• Supplier: R&D Systems
• Catalog: PDBP200
• Category: ELISA Kit
• Assay Type: Solid Phase Sandwich ELISA
• Sample Type: Cell Culture Supernates (50 µL), Bone Extracts (50 µL)
• Sensitivity: 29 pg/mL
• Range: 62.5 - 4,000 pg/mL (Cell Culture Supernates, Bone Extracts)
• Format: 96-well strip plate
• Description: The Quantikine Human BMP-2 Immunoassay is a 4.5 hour solid-phase ELISA designed to measure human BMP-2 in bone tissue extracts and cell culture supernates
• Gene: BMP2

Product References

Bone morphogenetic protein-2/-4 upregulation promoted by endothelial cells in - Bone morphogenetic protein-2/-4 upregulation promoted by endothelial cells in

Talavera-Adame D, Gupta A, Kurtovic S, Chaiboonma KL, Arumugaswami V, Dafoe DC. Stem Cells Dev. 2013 Dec 15;22(24):3252-60.

The serum bone morphogenetic protein-2 level in non-small-cell lung cancer - The serum bone morphogenetic protein-2 level in non-small-cell lung cancer

Choi YJ, Kim ST, Park KH, Oh SC, Seo JH, Shin SW, Kim JS, Kim YH. Med Oncol. 2012 Jun;29(2):582-8.

Bone morphogenetic protein-2 may represent the molecular link between oxidative - Bone morphogenetic protein-2 may represent the molecular link between oxidative

Dalfino G, Simone S, Porreca S, Cosola C, Balestra C, Manno C, Schena FP, Grandaliano G, Pertosa G. Atherosclerosis. 2010 Aug;211(2):418-23. doi:

Association of bone morphogenetic proteins with spinal fusion in ankylosing - Association of bone morphogenetic proteins with spinal fusion in ankylosing

Chen HA, Chen CH, Lin YJ, Chen PC, Chen WS, Lu CL, Chou CT. J Rheumatol. 2010 Oct;37(10):2126-32.

Isolation and characterization of CD146+ multipotent mesenchymal stromal cells. - Isolation and characterization of CD146+ multipotent mesenchymal stromal cells.

Sorrentino A, Ferracin M, Castelli G, Biffoni M, Tomaselli G, Baiocchi M, Fatica A, Negrini M, Peschle C, Valtieri M. Exp Hematol. 2008 Aug;36(8):1035-46.

Periodontal regeneration using ex vivo autologous stem cells engineered to - Periodontal regeneration using ex vivo autologous stem cells engineered to

Chen YL, Chen PK, Jeng LB, Huang CS, Yang LC, Chung HY, Chang SC. Gene Ther. 2008 Nov;15(22):1469-77.

Bone marrow cells are a rich source of growth factors and cytokines: implications - Bone marrow cells are a rich source of growth factors and cytokines: implications

Korf-Klingebiel M, Kempf T, Sauer T, Brinkmann E, Fischer P, Meyer GP, Ganser A, Drexler H, Wollert KC. Eur Heart J. 2008 Dec;29(23):2851-8.

Activin-like kinase receptor 1 (ALK1) in atherosclerotic lesions and vascular - Activin-like kinase receptor 1 (ALK1) in atherosclerotic lesions and vascular

Yao Y, Zebboudj AF, Torres A, Shao E, Bostrom K. Cardiovasc Res. 2007 May 1;74(2):279-89. Epub 2006 Sep 27.

Mesenchymal stem cells support migration, extracellular matrix invasion, - Mesenchymal stem cells support migration, extracellular matrix invasion,

Potapova IA, Gaudette GR, Brink PR, Robinson RB, Rosen MR, Cohen IS, Doronin SV. Stem Cells. 2007 Jul;25(7):1761-8. Epub 2007 Mar 29.

Targeted delivery system for juxtacrine signaling growth factor based on - Targeted delivery system for juxtacrine signaling growth factor based on

Liu HW, Chen CH, Tsai CL, Hsiue GH. Bone. 2006 Oct;39(4):825-36. Epub 2006 Jun 16.